Is IVIXF or SBUX a better dividend investment in 2026?

IVIXF currently yields 5420.05% with a 5% 5-year dividend growth rate. SBUX yields 2.75% with 5% growth. The better choice depends on your goal: IVIXF offers higher current income.

What is the dividend yield difference between IVIXF and SBUX?

IVIXF has a forward dividend yield of 5420.05% ($2.00/share annually). SBUX yields 2.75% ($2.46/share annually). The yield gap is 5417.30 percentage points.

Home › Compare › IVIXF vs SBUX

IVIXF vs SBUX: Dividend Comparison 2026

IVIXF yields 5420.05% · SBUX yields 2.75%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 IVIXF wins by $136326195118802.08M in total portfolio value

INVESTMENT

TIME HORIZON10 years

IVIXF

● Live price

5420.05%

Share price

$0.04

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$136326195118802.23M

Annual income

$131,551,666,493,773,860,000.00

Full IVIXF calculator →

SBUX

● Live price

2.75%

Share price

$89.59

Annual div

$2.46

5Y div CAGR

48.3%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$157.5K

Annual income

$65,840.13

Full SBUX calculator →

Portfolio growth — IVIXF vs SBUX

📍 IVIXF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	IVIXF	SBUX
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, IVIXF + SBUX cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

IVIXF pays

SBUX pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

IVIXF

Annual income on $10K today (after 15% tax)

$460,704.61/yr

After 10yr DRIP, annual income (after tax)

$111,818,916,519,707,770,000.00/yr

SBUX

Annual income on $10K today (after 15% tax)

$233.40/yr

After 10yr DRIP, annual income (after tax)

$55,964.11/yr

At 15% tax rate, IVIXF beats the other by $111,818,916,519,707,720,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of IVIXF + SBUX for your $10,000?

IVIXF: 50%SBUX: 50%

100% SBUX50/50100% IVIXF

Portfolio after 10yr

$68163097559401.20M

Annual income

$65,775,833,246,886,960,000.00/yr

Blended yield

96.50%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on SBUX right now

IVIXF

No analyst data

Altman Z

-30.2

Piotroski

1/9

SBUX

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$104.00

+16.1% upside vs current

Range: $90.00 — $120.00

Altman Z

2.6

Piotroski

5/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

IVIXF buys

SBUX buys

Politician	Chamber	Ticker	Type	Amount	Date
Shelley Moore Capito	🏛 Senate	$SBUX	▼ Sell	$1,001 - $15,000	2026-01-28
Shelley Moore Capito	🏛 Senate	$SBUX	▼ Sell	$1,001 - $15,000	2026-01-28
Sheldon Whitehouse	🏛 Senate	$SBUX	▼ Sell	$1,001 - $15,000	2026-01-09
Sheldon Whitehouse	🏛 Senate	$SBUX	▼ Sell	$1,001 - $15,000	2026-01-09
Sheldon Whitehouse	🏛 Senate	$SBUX	▼ Sell	$1,001 - $15,000	2026-01-09
Sheldon Whitehouse	🏛 Senate	$SBUX	▼ Sell	$1,001 - $15,000	2026-01-09
Dan Newhouse	🏢 House	$SBUX	▼ Sell	$1,001 - $15,000	2025-12-11
Ro Khanna	🏢 House	$SBUX	▼ Sell	$15,001 - $50,000	2025-10-07
Ro Khanna	🏢 House	$SBUX	▲ Buy	$15,001 - $50,000	2025-09-29
Ro Khanna	🏢 House	$SBUX	▼ Sell	$15,001 - $50,000	2025-08-26

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricIVIXFSBUX

Forward yield	5420.05% ✓	2.75%
Annual dividend / share	$2.00	$2.46 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	48.3% ✓
Portfolio after 10y	$136326195118802.23M ✓	$157.5K
Annual income after 10y	$131,551,666,493,773,860,000.00 ✓	$65,840.13
Total dividends collected	$136003983287005.17M ✓	$127.5K
Payment frequency	quarterly	quarterly
Sector	Stock	Consumer Discretionary

Year-by-year: IVIXF vs SBUX ($10,000, DRIP)

Year	IVIXF Portfolio	IVIXF Income/yr	SBUX Portfolio	SBUX Income/yr	Gap
1← crossover	$552,705	$542,005.42	$11,107	$407.21	+$541.6K → IVIXF
2	$28,588,529	$27,997,133.96	$12,512	$626.87	+$28.58M → IVIXF
3	$1,383,995,048	$1,353,405,322.61	$14,366	$978.69	+$1383.98M → IVIXF
4	$62,714,057,337	$61,233,182,635.19	$16,929	$1,557.50	+$62714.04M → IVIXF
5	$2,660,288,543,813	$2,593,184,502,462.66	$20,658	$2,543.80	+$2660288.52M → IVIXF
6	$105,651,330,702,723	$102,804,821,960,842.73	$26,406	$4,302.22	+$105651330.68M → IVIXF
7	$3,928,761,972,612,137	$3,815,715,048,760,222.50	$35,877	$7,622.00	+$3928761972.58M → IVIXF
8	$136,812,745,737,264,320	$132,608,970,426,569,340.00	$52,741	$14,352.64	+$136812745737.21M → IVIXF
9	$4,462,176,285,073,260,500	$4,315,786,647,134,387,700.00	$85,676	$29,243.03	+$4462176285073.17M → IVIXF
10	$136,326,195,118,802,240,000	$131,551,666,493,773,860,000.00	$157,513	$65,840.13	+$136326195118802.08M → IVIXF

IVIXF vs SBUX: Complete Analysis 2026

IVIXF — Stock

Invion Limited, a clinical-stage life-sciences company, researches and develops photodynamic therapy for the treatment of various cancers in Australia. The company is developing IVX-PDT, a photosensitizer agent to treat skin cancers, as well as solid cancers, including lung, prostrate, ovarian, and mesothelioma cancers. It has a research and development agreement with Hudson Institute of Medical Research to collaborate on a range of research and development projects for the Photosoft technology for the treatment of a range of cancers; and research agreement with Peter MacCallum Cancer Centre to undertake pre-clinical and in-vitro studies on Invion's IVX-PDT Photodynamic therapy for ano-genital cancers, including penile and anal cancer. The company was incorporated in 2000 and is headquartered in Melbourne, Australia.

Full IVIXF Calculator →

SBUX — Consumer Discretionary

Starbucks Corporation, together with its subsidiaries, operates as a roaster, marketer, and retailer of specialty coffee worldwide. The company operates through three segments: North America, International, and Channel Development. Its stores offer coffee and tea beverages, roasted whole beans and ground coffees, single serve products, and ready-to-drink beverages; and various food products, such as pastries, breakfast sandwiches, and lunch items. The company also licenses its trademarks through licensed stores, and grocery and foodservice accounts. The company offers its products under the Starbucks, Teavana, Seattle's Best Coffee, Evolution Fresh, Ethos, Starbucks Reserve, and Princi brands. As of October 3, 2021, it operated 16,826 company-operated and licensed stores in North America; and 17,007 company-operated and licensed stores internationally. The company was founded in 1971 and is based in Seattle, Washington.

Full SBUX Calculator →

📬

Get this IVIXF vs SBUX comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

IVIXF vs SCHD IVIXF vs JEPI IVIXF vs O IVIXF vs KO IVIXF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.